Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Brian J. Chen"'
Autor:
Shamia Hoque, Brian J Chen, Martin W Schoen, Kenneth R Carson, Jesse Keller, Bartlett J Witherspoon, Kevin B Knopf, Y Tony Yang, Benjamin Schooley, Chadi Nabhan, Oliver Sartor, Paul R Yarnold, Paul Ray, Laura Bobolts, William J Hrushesky, Michael Dickson, Charles L Bennett
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0234541 (2020)
Erythropoisis stimulating agent (ESA) use was addressed in Food and Drug Administration (FDA) Oncology Drug Advisory Committee (ODAC) meetings between 2004 and 2008. FDA safety-focused regulatory actions occurred in 2007 and 2008. In 2007, black box
Externí odkaz:
https://doaj.org/article/db22cc567bfb42b08476116e945c2620
Autor:
Shamia Hoque, Michael Dickson, Paul R. Yarnold, Oliver Sartor, Bartlett J. Witherspoon, Benjamin Schooley, Chadi Nabhan, Charles L. Bennett, Brian J. Chen, William J. M. Hrushesky, Y. Tony Yang, Martin W. Schoen, Kevin B. Knopf
Publikováno v:
International Journal of Cancer. 146:2829-2835
Erythropoiesis-stimulating agents (ESAs) are available to treat chemotherapy-induced anemia (CIA). In 2007-2008, regulatory notifications advised of venous thromboembolism and mortality risks while the Center for Medicare and Medicaid Services' restr
Autor:
Laura Rose Bobolts, Benjamin Schooley, Bartlett J. Witherspoon, Jesse Keller, Paul R. Yarnold, Brian J. Chen, Michael Dickson, Chadi Nabhan, Kenneth R. Carson, Martin W. Schoen, Kevin B. Knopf, Shamia Hoque, Y. Tony Yang, Oliver Sartor, William J. M. Hrushesky, Paul Ray, Charles L. Bennett
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 6, p e0234541 (2020)
PLoS ONE, Vol 15, Iss 6, p e0234541 (2020)
Erythropoisis stimulating agent (ESA) use was addressed in Food and Drug Administration (FDA) Oncology Drug Advisory Committee (ODAC) meetings between 2004 and 2008. FDA safety-focused regulatory actions occurred in 2007 and 2008. In 2007, black box
Autor:
Paul R. Yarnold, Dennis J. Cotter, Zaina P. Qureshi, Akida Lebby, William J. M. Hrushesky, Neset Hikmet, LeAnn B. Norris, Virginia Noxon, Brian J. Chen, Charles L. Bennett, Michael Dickson, Y. Tony Yang, Benjamin Schooley, Mae Thamer, Kevin B. Knopf
Publikováno v:
Journal of Oncology Practice. 13:e562-e573
Purpose: The US Food and Drug Administration (FDA) has approved epoetin and darbepoetin for chemotherapy-induced anemia (CIA). Approved epoetin and darbepoetin dosing schedules were three times per week and weekly, respectively, although off-label, l
Publikováno v:
Value in Health. 16(3)